Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2006 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Validity of fluorexon disodium versus sodium fluorescein for use in Goldmann tonometry.
Cornea. 2006 Jul;25(6):679-86. doi: 10.1097/01.ico.0000214233.74603.ce.
Cornea. 2006.
PMID: 17077660
Clinical Trial.
PURPOSE: To evaluate the safety, validity, and comfort of 0.35% fluorexon disodium and 0.4% benoxinate (Flura-Safe) compared with the gold standard of 0.25% sodium fluorescein and 0.4% benoxinate for Goldmann applanation tonometry (GAT). ...
PURPOSE: To evaluate the safety, validity, and comfort of 0.35% fluorexon disodium and 0.4% benoxinate (Flura-Safe) compared with the …
A comparison of Fluoracaine and Fluorox on corneal epithelial cell desquamation after Goldmann Applanation Tonometry.
Yeung KK, Kageyama JY, Carnevali T.
Yeung KK, et al.
Optometry. 2000 Jan;71(1):49-54.
Optometry. 2000.
PMID: 10680418
Clinical Trial.
BACKGROUND: The purpose of this study was to quality the frequency and amount of corneal desquamation from a sodium fluorescein/proparacaine combination (Fluoracaine) as compared with sodium fluorescein/benoxinate combination ophthalmic solution (Fluorox) after Goldmann Ap …
BACKGROUND: The purpose of this study was to quality the frequency and amount of corneal desquamation from a sodium fluorescein/proparacaine …
Item in Clipboard
Cite
Cite